TransMedics Grants Stock Options and Restricted Stock Units to New Employees

Reuters2025-12-25
TransMedics Grants Stock Options and Restricted Stock Units to New Employees

TransMedics Group Inc. has announced the grant of non-qualified stock options to purchase a total of 6,333 shares of its common stock and 4,205 restricted stock units to five new employees. The stock options have an exercise price of $129.35 per share, reflecting the closing price on December 22, 2025. Twenty-five percent of the stock options will vest on the first anniversary of each employee’s start date, with the remaining options vesting in equal monthly installments over the following three years. Restricted stock units will vest in four equal installments on the first four anniversaries of the employee’s start date. Both awards are subject to continued employment and are governed by the TransMedics Group, Inc. Inducement Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE53578) on December 24, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment